InSpek is building the sensing infrastructure that makes biological processes visible, controllable, and scalable. Biology illuminated, industries accelerated.

Biomanufacturing has reactors. It has automation. It has control systems. But it has never had real-time multiparameter visibility. Processes still run with limited insight, with delayed data, with reactive decisions. This leads to high failure rates, unpredictable scale-up, and slow development cycles.

You cannot control what you cannot see.


Biomanufacturing is entering a new phase: increasing process complexity, growth of cell and gene therapies, expansion of precision fermentation, and pressure on yield, cost, and scalability.
At the same time: AI is accelerating biotech discovery, Process Analytical Technology (PAT) is advancing, and photonic technologies are reaching industrial maturity.
But without continuous process data, AI lacks ground truth, automation lacks feedback, and optimization lacks signal.
The next era of biotech requires a new sensing infrastructure.

We start with sensing. But we are building more than a sensor. Hardware is the entry. Data is the leverage. Intelligence is the multiplier.
Our approach is structured in layers:

Our co-founders and advisors — Jérôme Michon (CEO), Ivan-Lazar Bundalo (CTO), Juejun Hu, Laurent Vivien and Derek Kita — plus a multidisciplinary team across photonics, chemistry, biology and engineering.

CEO and co-founder — Raman-on-chip pioneer.

CTO — leading PIC-based multisensor development.

Co-founder — MIT Professor in photonics for sensing.
The benefits of photonic integrated circuits speak to many industrial challenges: cost, size, ecological footprint. Integrated photonics is poised to have a strong impact on many industries and we at InSpek are determined to contribute to that movement.






InSpek’s technology originates from advanced research in photonics and multiparameter sensing.
The company was founded to bring these capabilities out of the lab and into real industrial environments, where processes need to be understood, controlled, and scaled.
We build technology that works beyond the lab.


Our goal is to enable a new generation of biomanufacturing: processes that are continuously monitored, systems that are fully understood, and production that can be reliably scaled.
Over time, this leads to reduced failure rates, lower waste, faster development cycles, and more accessible biological production.
Biology illuminated. Industries accelerated.
Quick answers to common questions about InSpek.
InSpek provides real-time multiparameter monitoring inside industrial processes. The system delivers continuous, in-line data on what is happening inside the process — enabling earlier detection of deviations, better process understanding, and tighter control.
Traditional monitoring relies on intermittent sampling, offline lab analysis, and delayed results. InSpek replaces this with continuous, in-line measurement and high-frequency, high-quality data. The result: earlier insight, faster decisions, and better outcomes.
Today, InSpek focuses on real-time multiparameter monitoring of metabolites and chemical compounds. The roadmap expands toward additional critical process parameters including pH, dissolved oxygen, temperature, and biomass — all integrated within a unified sensing architecture.
We typically begin with a discussion of your process and objectives, identification of the most relevant parameters, and a pilot or proof-of-concept. Get in touch to scope a conversation.
InSpek is based in France, with headquarters in Palaiseau and offices and laboratories at DocCity Suresnes. Visits by appointment.

InSpek headquarters.

Offices and laboratories at DocCity Suresnes.